25 XP   0   0   10

Tenaya Therapeutics Inc
Buy, Hold or Sell?

Let's analyse Tenaya Therapeutics Inc together

PenkeI guess you are interested in Tenaya Therapeutics Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Tenaya Therapeutics Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Tenaya Therapeutics Inc

I send you an email if I find something interesting about Tenaya Therapeutics Inc.

Quick analysis of Tenaya Therapeutics Inc (30 sec.)










What can you expect buying and holding a share of Tenaya Therapeutics Inc? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
$1.78
Expected worth in 1 year
$3.55
How sure are you?
15.4%

+ What do you gain per year?

Total Gains per Share
$1.78
Return On Investment
34.4%

For what price can you sell your share?

Current Price per Share
$5.16
Expected price per share
$3.55 - $7.01
How sure are you?
50%

1. Valuation of Tenaya Therapeutics Inc (5 min.)




Live pricePrice per Share (EOD)

$5.16

Intrinsic Value Per Share

$-12.26 - $-14.18

Total Value Per Share

$-10.48 - $-12.41

2. Growth of Tenaya Therapeutics Inc (5 min.)




Is Tenaya Therapeutics Inc growing?

Current yearPrevious yearGrowGrow %
How rich?$139.4m$167.3m-$43.7m-35.4%

How much money is Tenaya Therapeutics Inc making?

Current yearPrevious yearGrowGrow %
Making money-$31m-$30.9m-$105.2k-0.3%
Net Profit Margin0.0%0.0%--

How much money comes from the company's main activities?

3. Financial Health of Tenaya Therapeutics Inc (5 min.)




4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#326 / 1031

Most Revenue
#805 / 1031

Most Profit
#844 / 1031

Most Efficient
#259 / 1031

What can you expect buying and holding a share of Tenaya Therapeutics Inc? (5 min.)

Welcome investor! Tenaya Therapeutics Inc's management wants to use your money to grow the business. In return you get a share of Tenaya Therapeutics Inc.

What can you expect buying and holding a share of Tenaya Therapeutics Inc?

First you should know what it really means to hold a share of Tenaya Therapeutics Inc. And how you can make/lose money.

Speculation

The Price per Share of Tenaya Therapeutics Inc is $5.16. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Tenaya Therapeutics Inc.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Tenaya Therapeutics Inc, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $1.78. Based on the TTM, the Book Value Change Per Share is $0.44 per quarter. Based on the YOY, the Book Value Change Per Share is $-0.89 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Tenaya Therapeutics Inc.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.38-7.4%-0.40-7.7%-0.39-7.6%-0.32-6.3%-0.32-6.3%
Usd Book Value Change Per Share-0.32-6.3%0.448.6%-0.89-17.2%0.142.6%0.142.6%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-0.32-6.3%0.448.6%-0.89-17.2%0.142.6%0.142.6%
Usd Price Per Share3.24-3.63-5.58-5.88-5.88-
Price to Earnings Ratio-2.12--2.27--3.59--4.60--4.60-
Price-to-Total Gains Ratio-9.99--5.19--14.51--14.31--14.31-
Price to Book Ratio1.82-1.37-1.71-1.77-1.77-
Price-to-Total Gains Ratio-9.99--5.19--14.51--14.31--14.31-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share5.16
Number of shares193
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.440.14
Usd Total Gains Per Share0.440.14
Gains per Quarter (193 shares)85.6826.36
Gains per Year (193 shares)342.72105.45
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10343333010595
206856760211200
30102810190316305
40137113620422410
50171417050527515
60205620480633620
70239923910738725
80274227340844830
90308430770949935
10034273420010551040

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%0.012.00.00.0%0.013.00.00.0%0.013.00.00.0%0.013.00.00.0%
Book Value Change Per Share1.02.01.025.0%2.09.01.016.7%2.010.01.015.4%2.010.01.015.4%2.010.01.015.4%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.013.00.0%0.00.013.00.0%0.00.013.00.0%
Total Gains per Share1.02.01.025.0%2.09.01.016.7%2.010.01.015.4%2.010.01.015.4%2.010.01.015.4%

Fundamentals of Tenaya Therapeutics Inc

About Tenaya Therapeutics Inc

Tenaya Therapeutics, Inc., a biotechnology company, discovers, develops, and delivers therapies for heart disease in the United States. It develops its products through gene editing, cellular regeneration, and gene addition. The company is developing TN-201, a gene therapy for myosin binding protein C3-associated hypertrophic cardiomyopathy which is in phase 1 clinical trial; TN-301, a small molecule for heart failure with preserved ejection fraction which is in phase 1 clinical trial; and TN-401, a gene therapy for plakophilin 2-associated arrhythmogenic right ventricular cardiomyopathy which is in preclinical stage. It also develops an adeno-associated virus-based gene therapy designed to deliver the dworf gene for patient with dilated cardiomyopathy; and reprogramming program for heart failure due to prior myocardial infarction. Tenaya Therapeutics, Inc. was incorporated in 2016 and is headquartered in South San Francisco, California.

Fundamental data was last updated by Penke on 2024-03-22 05:44:05.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Tenaya Therapeutics Inc.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Tenaya Therapeutics Inc earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Tenaya Therapeutics Inc to the Biotechnology industry mean.
  • A Net Profit Margin of 0.0% means that $0.00 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Tenaya Therapeutics Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-0.0%
5Y-10Y-0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--171.8%+171.8%
TTM--205.8%+205.8%
YOY--262.1%+262.1%
5Y--455.6%+455.6%
10Y--589.0%+589.0%
1.1.2. Return on Assets

Shows how efficient Tenaya Therapeutics Inc is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Tenaya Therapeutics Inc to the Biotechnology industry mean.
  • -17.6% Return on Assets means that Tenaya Therapeutics Inc generated $-0.18 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Tenaya Therapeutics Inc:

  • The MRQ is -17.6%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -15.2%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-17.6%TTM-15.2%-2.4%
TTM-15.2%YOY-11.9%-3.2%
TTM-15.2%5Y-11.3%-3.9%
5Y-11.3%10Y-11.3%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-17.6%-12.5%-5.1%
TTM-15.2%-12.2%-3.0%
YOY-11.9%-11.2%-0.7%
5Y-11.3%-13.4%+2.1%
10Y-11.3%-14.7%+3.4%
1.1.3. Return on Equity

Shows how efficient Tenaya Therapeutics Inc is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Tenaya Therapeutics Inc to the Biotechnology industry mean.
  • -21.5% Return on Equity means Tenaya Therapeutics Inc generated $-0.21 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Tenaya Therapeutics Inc:

  • The MRQ is -21.5%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -17.8%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-21.5%TTM-17.8%-3.6%
TTM-17.8%YOY-13.6%-4.2%
TTM-17.8%5Y-10.9%-7.0%
5Y-10.9%10Y-10.9%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-21.5%-15.8%-5.7%
TTM-17.8%-15.7%-2.1%
YOY-13.6%-13.9%+0.3%
5Y-10.9%-18.3%+7.4%
10Y-10.9%-19.2%+8.3%

1.2. Operating Efficiency of Tenaya Therapeutics Inc.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Tenaya Therapeutics Inc is operating .

  • Measures how much profit Tenaya Therapeutics Inc makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Tenaya Therapeutics Inc to the Biotechnology industry mean.
  • An Operating Margin of 0.0% means the company generated $0.00  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Tenaya Therapeutics Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-0.0%
5Y-10Y-0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--299.1%+299.1%
TTM--210.1%+210.1%
YOY--279.7%+279.7%
5Y--459.9%+459.9%
10Y--596.9%+596.9%
1.2.2. Operating Ratio

Measures how efficient Tenaya Therapeutics Inc is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 0.00 means that the operating costs are $0.00 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Tenaya Therapeutics Inc:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY-0.000
TTM-5Y-0.000
5Y-10Y-0.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-2.861-2.861
TTM-3.193-3.193
YOY-3.615-3.615
5Y-5.560-5.560
10Y-7.396-7.396

1.3. Liquidity of Tenaya Therapeutics Inc.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Tenaya Therapeutics Inc is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 4.91 means the company has $4.91 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Tenaya Therapeutics Inc:

  • The MRQ is 4.908. The company is very able to pay all its short-term debts. +2
  • The TTM is 6.526. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ4.908TTM6.526-1.618
TTM6.526YOY9.490-2.964
TTM6.5265Y11.991-5.465
5Y11.99110Y11.9910.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ4.9083.986+0.922
TTM6.5264.440+2.086
YOY9.4905.552+3.938
5Y11.9916.158+5.833
10Y11.9916.492+5.499
1.3.2. Quick Ratio

Measures if Tenaya Therapeutics Inc is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Tenaya Therapeutics Inc to the Biotechnology industry mean.
  • A Quick Ratio of 7.20 means the company can pay off $7.20 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Tenaya Therapeutics Inc:

  • The MRQ is 7.197. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 9.369. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ7.197TTM9.369-2.172
TTM9.369YOY16.416-7.048
TTM9.3695Y16.580-7.211
5Y16.58010Y16.5800.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ7.1973.638+3.559
TTM9.3694.168+5.201
YOY16.4165.515+10.901
5Y16.5806.012+10.568
10Y16.5806.209+10.371

1.4. Solvency of Tenaya Therapeutics Inc.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Tenaya Therapeutics Inc assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Tenaya Therapeutics Inc to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.18 means that Tenaya Therapeutics Inc assets are financed with 18.2% credit (debt) and the remaining percentage (100% - 18.2%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Tenaya Therapeutics Inc:

  • The MRQ is 0.182. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.367. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.182TTM0.367-0.185
TTM0.367YOY0.343+0.024
TTM0.3675Y0.605-0.238
5Y0.60510Y0.6050.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1820.335-0.153
TTM0.3670.330+0.037
YOY0.3430.267+0.076
5Y0.6050.367+0.238
10Y0.6050.378+0.227
1.4.2. Debt to Equity Ratio

Measures if Tenaya Therapeutics Inc is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Tenaya Therapeutics Inc to the Biotechnology industry mean.
  • A Debt to Equity ratio of 22.3% means that company has $0.22 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Tenaya Therapeutics Inc:

  • The MRQ is 0.223. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.424. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.223TTM0.424-0.201
TTM0.424YOY0.393+0.031
TTM0.4245Y0.268+0.156
5Y0.26810Y0.2680.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.2230.376-0.153
TTM0.4240.398+0.026
YOY0.3930.334+0.059
5Y0.2680.429-0.161
10Y0.2680.476-0.208

2. Market Valuation of Tenaya Therapeutics Inc

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Tenaya Therapeutics Inc generates.

  • Above 15 is considered overpriced but always compare Tenaya Therapeutics Inc to the Biotechnology industry mean.
  • A PE ratio of -2.12 means the investor is paying $-2.12 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Tenaya Therapeutics Inc:

  • The EOD is -3.384. Based on the earnings, the company is expensive. -2
  • The MRQ is -2.125. Based on the earnings, the company is expensive. -2
  • The TTM is -2.267. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-3.384MRQ-2.125-1.259
MRQ-2.125TTM-2.267+0.142
TTM-2.267YOY-3.592+1.325
TTM-2.2675Y-4.604+2.337
5Y-4.60410Y-4.6040.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-3.384-2.643-0.741
MRQ-2.125-2.418+0.293
TTM-2.267-2.742+0.475
YOY-3.592-4.123+0.531
5Y-4.604-6.257+1.653
10Y-4.604-6.478+1.874
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Tenaya Therapeutics Inc:

  • The EOD is -4.538. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -2.850. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -2.784. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-4.538MRQ-2.850-1.689
MRQ-2.850TTM-2.784-0.066
TTM-2.784YOY-3.265+0.481
TTM-2.7845Y-4.290+1.507
5Y-4.29010Y-4.2900.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-4.538-3.244-1.294
MRQ-2.850-2.939+0.089
TTM-2.784-3.478+0.694
YOY-3.265-5.592+2.327
5Y-4.290-8.473+4.183
10Y-4.290-8.881+4.591
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Tenaya Therapeutics Inc is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 1.82 means the investor is paying $1.82 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Tenaya Therapeutics Inc:

  • The EOD is 2.906. Based on the equity, the company is underpriced. +1
  • The MRQ is 1.825. Based on the equity, the company is underpriced. +1
  • The TTM is 1.366. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD2.906MRQ1.825+1.081
MRQ1.825TTM1.366+0.458
TTM1.366YOY1.712-0.346
TTM1.3665Y1.769-0.402
5Y1.76910Y1.7690.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD2.9062.124+0.782
MRQ1.8252.041-0.216
TTM1.3662.118-0.752
YOY1.7122.915-1.203
5Y1.7693.682-1.913
10Y1.7694.114-2.345
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Tenaya Therapeutics Inc.

3.1. Institutions holding Tenaya Therapeutics Inc

Institutions are holding 77.195% of the shares of Tenaya Therapeutics Inc.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2023-12-31Column Group LLC13.801420.1198940029000
2023-09-30RA Capital Management, LLC9.8640.3373671848365100010.7293
2023-12-31Casdin Capital, LLC9.36912.0295638137700
2023-12-31T. Rowe Price Associates, Inc.6.67230.0024544543693771.5503
2023-12-31BlackRock Inc5.55980.00033786824-896343-19.1397
2023-09-30FMR Inc4.67880.00073186751-567488-15.1159
2023-09-30Vanguard Group Inc3.18280.000121678681684898.4271
2023-09-30Citadel Advisors Llc3.09180.001221058771090819107.4637
2023-09-30Euclidean Capital LLC2.98250.565220314101115705121.8411
2023-09-30Alphabet Inc1.34440.1591570500
2023-09-30State Street Corporation1.29060.0001879063568656.9162
2023-09-30Geode Capital Management, LLC1.2820.0003873213536416.545
2023-09-30Millennium Management LLC1.08290.001737573399764118.3402
2023-09-30Harvard Management Co Inc0.98850.193867327000
2023-12-31Renaissance Technologies Corp0.70810.00244823254872511.2373
2023-12-31GSA Capital Partners LLP0.69130.128347084510735229.5334
2023-12-31StepStone Group LLC0.67850.269546216300
2023-09-30Northern Trust Corp0.63020.0002429233116252.7837
2023-12-31Two Sigma Investments LLC0.48780.00153322528066632.063
2023-12-31Trustees Of Columbia University In The City Of New York0.42851.995429182800
Total 68.815325.798646870893+2390197+5.1%

3.2. Funds holding Tenaya Therapeutics Inc

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2023-12-31T. Rowe Price New Horizons3.55420.03172420804-7739-0.3187
2023-12-31US Small-Cap Growth II Equity Comp3.55420.03162420804-7739-0.3187
2024-02-29Vanguard Total Stock Mkt Idx Inv2.67110.0007181930500
2024-01-31Fidelity Select Biotechnology2.63960.1639179784122856214.5648
2024-02-29iShares Russell 2000 ETF1.65360.01081126265-184-0.0163
2023-12-31T. Rowe Price Health Sciences1.56970.02361069162-22219-2.0359
2023-12-31Fidelity Small Cap Growth1.16240.044979174400
2024-02-29Vanguard Institutional Extnd Mkt Idx Tr0.89180.0035607407325405.6604
2023-12-31Fidelity Small Cap Index0.65610.005744686867161.5258
2024-01-31BlackRock Health Sciences Opps Inv A0.63290.021843107600
2024-02-01iShares Russell 2000 Value ETF0.60960.01674152295260.1268
2023-12-31T. Rowe Price New Horizons Tr-Z0.50130.025634141477392.3193
2023-12-31Fidelity Small Cap Growth K60.42870.045129196600
2024-02-29State St Russell Sm/Mid Cp® Indx NL Cl C0.3990.003927174900
2024-01-31Fidelity Extended Market Index0.35020.002823849800
2023-12-31Bridgeway Ultra-Small Company Market0.26710.317218190000
2024-02-29State St Russell Sm Cap® Indx SL Cl I0.25150.010817128900
2024-01-31BlackRock Health Sciences Term Trust0.24330.03716572900
2024-02-29Vanguard Russell 2000 ETF0.24250.0103165192131728.6646
2024-02-29Tema Cardiovascular and Metabolic ETF0.21241.797414469830572.1583
Total 22.49122.60515318940+254431+1.7%

3.3. Insider Transactions

Insiders are holding 1.533% of the shares of Tenaya Therapeutics Inc.

DateOwnerTypeAmountPricePost Transaction AmountLink
2024-03-05Timothy HoeySELL33007
2024-02-20Timothy HoeySELL65695.34
2024-02-16Faraz AliSELL63585.86
2024-02-16Timothy HoeySELL46815.86
2024-02-12Group Gp Lp Column IiiBUY22222224.5
2023-08-29Timothy HoeySELL72434.26
2023-08-16Faraz AliSELL55633.81
2023-08-16Timothy HoeySELL40073.81

4. Summary

4.1. Key Performance Indicators

The key performance indicators of Tenaya Therapeutics Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.3240.444-173%-0.887+173%0.137-337%0.137-337%
Book Value Per Share--1.7761.574+13%2.131-17%1.432+24%1.432+24%
Current Ratio--4.9086.526-25%9.490-48%11.991-59%11.991-59%
Debt To Asset Ratio--0.1820.367-50%0.343-47%0.605-70%0.605-70%
Debt To Equity Ratio--0.2230.424-47%0.393-43%0.268-17%0.268-17%
Dividend Per Share----0%-0%-0%-0%
Eps---0.381-0.395+4%-0.394+3%-0.324-15%-0.324-15%
Free Cash Flow Per Share---0.284-0.329+16%-0.398+40%-0.326+15%-0.326+15%
Free Cash Flow To Equity Per Share---0.280-0.316+13%-0.151-46%0.043-751%0.043-751%
Gross Profit Margin--1.1001.096+0%1.000+10%1.029+7%1.029+7%
Intrinsic Value_10Y_max---14.182--------
Intrinsic Value_10Y_min---12.257--------
Intrinsic Value_1Y_max---1.349--------
Intrinsic Value_1Y_min---1.325--------
Intrinsic Value_3Y_max---4.108--------
Intrinsic Value_3Y_min---3.920--------
Intrinsic Value_5Y_max---6.933--------
Intrinsic Value_5Y_min---6.430--------
Market Cap405143055.360+37%254392151.040284817138.240-11%438119815.680-42%461614247.483-45%461614247.483-45%
Net Profit Margin----0%-0%-0%-0%
Operating Margin----0%-0%-0%-0%
Operating Ratio----0%-0%-0%-0%
Pb Ratio2.906+37%1.8251.366+34%1.712+7%1.769+3%1.769+3%
Pe Ratio-3.384-59%-2.125-2.267+7%-3.592+69%-4.604+117%-4.604+117%
Price Per Share5.160+37%3.2403.628-11%5.580-42%5.879-45%5.879-45%
Price To Free Cash Flow Ratio-4.538-59%-2.850-2.784-2%-3.265+15%-4.290+51%-4.290+51%
Price To Total Gains Ratio-15.913-59%-9.992-5.185-48%-14.505+45%-14.306+43%-14.306+43%
Quick Ratio--7.1979.369-23%16.416-56%16.580-57%16.580-57%
Return On Assets---0.176-0.152-14%-0.119-32%-0.113-36%-0.113-36%
Return On Equity---0.215-0.178-17%-0.136-37%-0.109-49%-0.109-49%
Total Gains Per Share---0.3240.444-173%-0.887+173%0.137-337%0.137-337%
Usd Book Value--139424000.000123562000.000+13%167323000.000-17%112459307.692+24%112459307.692+24%
Usd Book Value Change Per Share---0.3240.444-173%-0.887+173%0.137-337%0.137-337%
Usd Book Value Per Share--1.7761.574+13%2.131-17%1.432+24%1.432+24%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---0.381-0.395+4%-0.394+3%-0.324-15%-0.324-15%
Usd Free Cash Flow---22318000.000-25827750.000+16%-31263500.000+40%-25605846.154+15%-25605846.154+15%
Usd Free Cash Flow Per Share---0.284-0.329+16%-0.398+40%-0.326+15%-0.326+15%
Usd Free Cash Flow To Equity Per Share---0.280-0.316+13%-0.151-46%0.043-751%0.043-751%
Usd Market Cap405143055.360+37%254392151.040284817138.240-11%438119815.680-42%461614247.483-45%461614247.483-45%
Usd Price Per Share5.160+37%3.2403.628-11%5.580-42%5.879-45%5.879-45%
Usd Profit---29935000.000-31021000.000+4%-30915761.000+3%-25445080.308-15%-25445080.308-15%
Usd Revenue----0%-0%-0%-0%
Usd Total Gains Per Share---0.3240.444-173%-0.887+173%0.137-337%0.137-337%
 EOD+5 -3MRQTTM+16 -14YOY+15 -155Y+11 -1910Y+11 -19

4.2. Fundamental Score

Let's check the fundamental score of Tenaya Therapeutics Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-3.384
Price to Book Ratio (EOD)Between0-12.906
Net Profit Margin (MRQ)Greater than00.000
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than17.197
Current Ratio (MRQ)Greater than14.908
Debt to Asset Ratio (MRQ)Less than10.182
Debt to Equity Ratio (MRQ)Less than10.223
Return on Equity (MRQ)Greater than0.15-0.215
Return on Assets (MRQ)Greater than0.05-0.176
Total4/10 (40.0%)

4.3. Technical Score

Let's check the technical score of Tenaya Therapeutics Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5049.546
Ma 20Greater thanMa 505.508
Ma 50Greater thanMa 1005.116
Ma 100Greater thanMa 2003.733
OpenGreater thanClose4.890
Total2/5 (40.0%)



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in USD. All numbers in thousands.

Summary
Total Assets170,515
Total Liabilities31,091
Total Stockholder Equity139,424
 As reported
Total Liabilities 31,091
Total Stockholder Equity+ 139,424
Total Assets = 170,515

Assets

Total Assets170,515
Total Current Assets111,582
Long-term Assets58,933
Total Current Assets
Cash And Cash Equivalents 45,681
Short-term Investments 58,961
Other Current Assets 6,940
Total Current Assets  (as reported)111,582
Total Current Assets  (calculated)111,582
+/-0
Long-term Assets
Property Plant Equipment 53,256
Long-term Assets Other 4,995
Long-term Assets  (as reported)58,933
Long-term Assets  (calculated)58,251
+/- 682

Liabilities & Shareholders' Equity

Total Current Liabilities22,733
Long-term Liabilities8,358
Total Stockholder Equity139,424
Total Current Liabilities
Short-term Debt 4,319
Accounts payable 5,630
Other Current Liabilities 12,784
Total Current Liabilities  (as reported)22,733
Total Current Liabilities  (calculated)22,733
+/-0
Long-term Liabilities
Capital Lease Obligations Min Short Term Debt8,105
Long-term Liabilities Other 253
Long-term Liabilities  (as reported)8,358
Long-term Liabilities  (calculated)8,358
+/-0
Total Stockholder Equity
Common Stock7
Retained Earnings -403,282
Accumulated Other Comprehensive Income -106
Other Stockholders Equity 542,805
Total Stockholder Equity (as reported)139,424
Total Stockholder Equity (calculated)139,424
+/-0
Other
Capital Stock7
Cash and Short Term Investments 104,642
Common Stock Shares Outstanding 68,330
Liabilities and Stockholders Equity 170,515
Net Debt -33,257
Net Invested Capital 139,424
Net Working Capital 88,849
Property Plant and Equipment Gross 77,596
Short Long Term Debt Total 12,424



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-31
> Total Assets 
0
0
0
148,161
159,757
156,895
331,794
314,189
281,497
255,929
226,310
278,945
245,341
220,754
193,397
170,515
170,515193,397220,754245,341278,945226,310255,929281,497314,189331,794156,895159,757148,161000
   > Total Current Assets 
0
0
0
129,964
129,750
113,222
284,822
255,358
213,782
185,693
157,067
193,754
154,628
138,906
126,828
111,582
111,582126,828138,906154,628193,754157,067185,693213,782255,358284,822113,222129,750129,964000
       Cash And Cash Equivalents 
0
0
0
128,535
128,439
111,886
117,077
38,129
25,970
31,010
34,494
95,272
72,542
75,565
82,153
45,681
45,68182,15375,56572,54295,27234,49431,01025,97038,129117,077111,886128,439128,535000
       Short-term Investments 
0
0
0
0
0
0
163,388
213,171
184,484
149,906
114,956
91,255
75,271
56,940
39,600
58,961
58,96139,60056,94075,27191,255114,956149,906184,484213,171163,388000000
       Net Receivables 
0
0
0
0
0
0
0
0
0
2,000
2,000
0
0
0
0
0
000002,0002,000000000000
       Other Current Assets 
0
0
0
1,429
1,311
1,336
4,357
4
3,328
4,777
7,617
7,227
6,815
6,401
5,075
6,940
6,9405,0756,4016,8157,2277,6174,7773,32844,3571,3361,3111,429000
   > Long-term Assets 
0
0
0
18,197
30,007
43,673
46,972
58,831
67,715
70,236
69,243
85,191
90,713
81,848
66,569
58,933
58,93366,56981,84890,71385,19169,24370,23667,71558,83146,97243,67330,00718,197000
       Property Plant Equipment 
0
0
0
17,185
25,682
37,225
42,897
54,705
60,737
66,127
64,593
62,695
60,261
57,172
54,468
53,256
53,25654,46857,17260,26162,69564,59366,12760,73754,70542,89737,22525,68217,185000
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
17,703
25,822
19,136
6,367
0
06,36719,13625,82217,70300000000000
       Other Assets 
0
0
0
0
4,325
6,448
4,075
4,126
3,978
145,249
4,650
4,793
0
5,540
0
0
005,54004,7934,650145,2493,9784,1264,0756,4484,3250000
> Total Liabilities 
0
0
0
229,476
253,700
265,431
28,095
35,663
32,400
32,062
29,982
278,945
245,341
30,814
28,513
31,091
31,09128,51330,814245,341278,94529,98232,06232,40035,66328,095265,431253,700229,476000
   > Total Current Liabilities 
0
0
0
5,041
5,910
9,800
13,692
21,774
19,095
18,741
17,716
24,248
19,305
20,917
19,377
22,733
22,73319,37720,91719,30524,24817,71618,74119,09521,77413,6929,8005,9105,041000
       Short-term Debt 
0
0
0
0
1,690
1,637
1,914
1,994
2,075
3,896
4,016
4,006
3,730
3,447
3,154
4,319
4,3193,1543,4473,7304,0064,0163,8962,0751,9941,9141,6371,6900000
       Accounts payable 
0
0
0
1,017
2,092
5,020
6,171
10,721
8,888
5,347
5,312
9,578
7,430
8,484
5,902
5,630
5,6305,9028,4847,4309,5785,3125,3478,88810,7216,1715,0202,0921,017000
       Other Current Liabilities 
0
0
0
4,024
141
200
514
162
8,132
9,498
8,388
10,664
8,145
778
458
12,784
12,7844587788,14510,6648,3889,4988,1321625142001414,024000
   > Long-term Liabilities 
0
0
0
224,435
247,790
255,631
14,403
13,889
13,305
13,321
12,266
11,321
10,624
9,897
9,136
8,358
8,3589,1369,89710,62411,32112,26613,32113,30513,88914,403255,631247,790224,435000
       Warrants
0
0
0
0
0
240,735
0
0
0
0
0
0
0
0
0
0
0000000000240,73500000
       Other Liabilities 
0
0
0
0
19
3
96
182
212
217
223
228
0
240
0
0
002400228223217212182963190000
       Deferred Long Term Liability 
0
0
0
0
100
2,500
0
0
0
0
0
0
0
0
0
0
00000000002,5001000000
> Total Stockholder Equity
0
0
0
-81,315
-93,943
-108,536
303,699
278,526
249,097
223,867
196,328
243,376
215,412
189,940
164,884
139,424
139,424164,884189,940215,412243,376196,328223,867249,097278,526303,699-108,536-93,943-81,315000
   Common Stock
0
0
0
0
1
0
4
4
4
4
4
7
7
7
7
7
7777744444010000
   Retained Earnings Total Equity000-310,935-279,198-245,682-214,986-186,589-155,533-129,382-111,12000000
   Accumulated Other Comprehensive Income -106-261-333-120-378-767-739-631-141-23000000
   Capital Surplus 
0
0
0
0
0
2,596
433,112
434,196
436,313
439,588
442,773
522,945
526,460
0
0
0
000526,460522,945442,773439,588436,313434,196433,1122,59600000
   Treasury Stock0000000000000000
   Other Stockholders Equity 
0
0
0
1,497
1,967
-238,151
101,306
434
436,313
439,588
442,773
522,945
526,460
534,470
538,485
542,805
542,805538,485534,470526,460522,945442,773439,588436,313434101,306-238,1511,9671,497000



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue0
Cost of Revenue-8,687
Gross Profit-8,687-8,687
 
Operating Income (+$)
Gross Profit-8,687
Operating Expense-122,506
Operating Income-131,193-131,193
 
Operating Expense (+$)
Research Development98,038
Selling General Administrative33,155
Selling And Marketing Expenses8,687
Operating Expense122,506139,880
 
Net Interest Income (+$)
Interest Income6,623
Interest Expense-0
Other Finance Cost-0
Net Interest Income6,623
 
Pretax Income (+$)
Operating Income-131,193
Net Interest Income6,623
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-124,084-138,302
EBIT - interestExpense = -131,193
-124,084
-124,084
Interest Expense0
Earnings Before Interest and Taxes (EBIT)-131,193-124,084
Earnings Before Interest and Taxes (EBITDA)-122,506
 
After tax Income (+$)
Income Before Tax-124,084
Tax Provision-0
Net Income From Continuing Ops-127,665-124,084
Net Income-124,084
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses131,193
Total Other Income/Expenses Net7,109-6,623
 

Technical Analysis of Tenaya Therapeutics Inc
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Tenaya Therapeutics Inc. The general trend of Tenaya Therapeutics Inc is BULLISH with 42.9% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Tenaya Therapeutics Inc's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (42.9%) Bearish trend (-42.9%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Tenaya Therapeutics Inc.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is -1/(-1 +1).

  • Around resistance: The price is trading arround resistance levels. This can be considered as a potential exit level. -1

The bullish price targets are: 5.07 < 6.61 < 7.01.

The bearish price targets are: 4.11 > 4.11 > 3.55.

Tweet this
Tenaya Therapeutics Inc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Tenaya Therapeutics Inc. The current mas is .

The long score for the Moving Averages is 10/14.
The longshort score for the Moving Averages is 6/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Tenaya Therapeutics Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Tenaya Therapeutics Inc. The current macd is -0.13038124.

The long score for the Moving Average Convergence/Divergence (MACD) is 1/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -2/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Tenaya Therapeutics Inc price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Tenaya Therapeutics Inc. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Tenaya Therapeutics Inc price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Tenaya Therapeutics Inc Daily Moving Average Convergence/Divergence (MACD) ChartTenaya Therapeutics Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Tenaya Therapeutics Inc. The current adx is 29.31.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -3/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Tenaya Therapeutics Inc shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX > 25 && ADX trending down: The ADX is above 25 and indicates a strong bearish trend. The ADX is declining, the bearish trend is weakening. Could be a potential reversal to the upside. -2
Tenaya Therapeutics Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Tenaya Therapeutics Inc. The current sar is 5.38934395.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Tenaya Therapeutics Inc Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Tenaya Therapeutics Inc. The current rsi is 49.55. The current phase is Correction in bull market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is -2/(-13 +13).

  • Correction in bull market: Moderate price decline, potential pause in the uptrend. Reassess the market, wait for signs of stabilization.
  • Trending up: The RSI is trending up. +1
Tenaya Therapeutics Inc Daily Relative Strength Index (RSI) ChartTenaya Therapeutics Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Tenaya Therapeutics Inc. The current phase is Correction in bull market.

The long score for the Stochastic Oscillator is 3/6.
The longshort score for the Stochastic Oscillator is 2/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Tenaya Therapeutics Inc price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Tenaya Therapeutics Inc Daily Stochastic Oscillator ChartTenaya Therapeutics Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Tenaya Therapeutics Inc. The current cci is -44.00095772.

Tenaya Therapeutics Inc Daily Commodity Channel Index (CCI) ChartTenaya Therapeutics Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Tenaya Therapeutics Inc. The current cmo is 0.23398891.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Tenaya Therapeutics Inc Daily Chande Momentum Oscillator (CMO) ChartTenaya Therapeutics Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Tenaya Therapeutics Inc. The current willr is -60.6741573.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Tenaya Therapeutics Inc is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Tenaya Therapeutics Inc Daily Williams %R ChartTenaya Therapeutics Inc Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Tenaya Therapeutics Inc.

Tenaya Therapeutics Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Tenaya Therapeutics Inc. The current atr is 0.50491004.

Tenaya Therapeutics Inc Daily Average True Range (ATR) ChartTenaya Therapeutics Inc Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Tenaya Therapeutics Inc. The current obv is 6,142,668.

Tenaya Therapeutics Inc Daily On-Balance Volume (OBV) ChartTenaya Therapeutics Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Tenaya Therapeutics Inc. The current mfi is 39.83.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Tenaya Therapeutics Inc Daily Money Flow Index (MFI) ChartTenaya Therapeutics Inc Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Tenaya Therapeutics Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-03DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-11-06STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-07DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-11-10SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2023-11-14STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-15STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-16WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-11-17STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-21STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-11-22DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2023-11-24STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-29SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-30STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-01CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-05STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-06STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-07CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2023-12-08STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-11STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-13CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2023-12-14STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-19STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-20STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-21STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-22ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-26MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-12-28STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-29MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-01-03RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2024-01-04SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-01-08STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-10MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-16CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-18STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-19MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-22STOCH LONG EXITThe %K line crosses below the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-01-24MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-01-25RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2024-01-29STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-30RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-01STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-06MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-07STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-08MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-09WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-12STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-13RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2024-02-14STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-15WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-16BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-20RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-21MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-02-22SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-23STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-26STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-28SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-02-29STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-01MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-06RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2024-03-08MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-03-11SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-13WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-14DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-18STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-19CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-20STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-22STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-25STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-27CMO LONG ENTRY SHORT CLOSEZero line crossover to upside

6.3. Candlestick Patterns

Tenaya Therapeutics Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Tenaya Therapeutics Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5049.546
Ma 20Greater thanMa 505.508
Ma 50Greater thanMa 1005.116
Ma 100Greater thanMa 2003.733
OpenGreater thanClose4.890
Total2/5 (40.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Tenaya Therapeutics Inc with someone you think should read this too:
  • Are you bullish or bearish on Tenaya Therapeutics Inc? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Tenaya Therapeutics Inc? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Tenaya Therapeutics Inc

I send you an email if I find something interesting about Tenaya Therapeutics Inc.


Comments

How you think about this?

Leave a comment

Stay informed about Tenaya Therapeutics Inc.

Receive notifications about Tenaya Therapeutics Inc in your mailbox!